Management of Chronic Cervicitis by Oral administration of Tablet Triphala Guggulu and Yoni Pichu with Darvi Taila

Effect of Triphala Guggulu orally along with Darvi Taila Yoni Pichu in the management of Chronic Cervicitis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064419

Enrollment

Registered

2024-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Only married women of different age group and parity. 2. Patients presenting with at least any 3 of the following clinical signs and symptomatology of chronic Cervicitis like - a. Patients presenting with mucopurulent discharge p/v and endocervical bleed. b. Patients having inflammatory Cervical Pap smear. c. Patients presenting with clinical features of dyspareunia and cervical tenderness. d. Patients presenting with clinical features of cervical congestion /strawberry cervix. e. Patients presenting with intermenstrual/ post coital bleeding. f. Patients presenting with other symptoms of cervicitis like back ache and lower abdominal pain.

Exclusion criteria

Exclusion criteria: 1. Unmarried 2. Pregnant women and Patients suffering from any specific organic lesions such as Tuberculosis, acute or chronic respiratory diseases, cardiac diseases, renal diseases, Diabetes mellitus, Hypertension etc. 3. Women with carcinoma of cervix, benign or malignant growth of reproductive tract, any degree of genital prolapses. 4. Patients having their HIV and VDRL reactive. 16 5. Patients with Cervical Pap smear showing either CIN or papilloma virus infection or invasive malignancy. 6. Patients having Acute cervicitis. 7. Patients having Acute Pelvic inflammatory disease. 8. Patients with h/o surgery of cervix.

Design outcomes

Primary

Measure	Time frame
Based on Subjective and Objective criteria and Laboratory investigations Subjective criteria: ? Vaginal discharge ? Post coital bleeding ? Back ache ? Inter menstrual spotting ? Dyspareunia Objective criteria: ? Cervical Congestion ? Cervical discharge ? Vaginal discharge ? Cervical tenderness ? Contact bleeding Laboratory investigations ? Positive inflammatory Pap smear ? Positive endocervical swab culture ? ColposcopyTimepoint: 3 Follow ups with equal interval of 15 days	—

Measure

Time frame

Based on Subjective and Objective criteria and Laboratory investigations Subjective criteria: ? Vaginal discharge ? Post coital bleeding ? Back ache ? Inter menstrual spotting ? Dyspareunia Objective criteria: ? Cervical Congestion ? Cervical discharge ? Vaginal discharge ? Cervical tenderness ? Contact bleeding Laboratory investigations ? Positive inflammatory Pap smear ? Positive endocervical swab culture ? ColposcopyTimepoint: 3 Follow ups with equal interval of 15 days

—

Secondary

Measure	Time frame
Reduced inflammation ,alleviated symptoms and improved quality of life among study participantsTimepoint: 3 follow ups with Regular interval of 15 days.2 follow ups with medication and 1 follow up without medication	—

Countries

India

Contacts

Public ContactDr Vishwesh B N

Banaras Hindu University

vishweshbn@gmail.com8277033135

Outcome results